Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phas...
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Conference item |
| Cyhoeddwyd: |
Elsevier
2017
|
| _version_ | 1826268258993438720 |
|---|---|
| author | Holyoake, D Partridge, M Hurt, C Mukherjee, S Hawkins, M |
| author_facet | Holyoake, D Partridge, M Hurt, C Mukherjee, S Hawkins, M |
| author_sort | Holyoake, D |
| collection | OXFORD |
| description | Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phase-II clinical trials of locally-advanced pancreatic cancer (LAPC). |
| first_indexed | 2024-03-06T21:06:55Z |
| format | Conference item |
| id | oxford-uuid:3cc91fd6-b688-4a67-8f4b-d281c49aaa3f |
| institution | University of Oxford |
| last_indexed | 2024-03-06T21:06:55Z |
| publishDate | 2017 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:3cc91fd6-b688-4a67-8f4b-d281c49aaa3f2022-03-26T14:15:41ZStomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapyConference itemhttp://purl.org/coar/resource_type/c_5794uuid:3cc91fd6-b688-4a67-8f4b-d281c49aaa3fSymplectic Elements at OxfordElsevier2017Holyoake, DPartridge, MHurt, CMukherjee, SHawkins, MGastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phase-II clinical trials of locally-advanced pancreatic cancer (LAPC). |
| spellingShingle | Holyoake, D Partridge, M Hurt, C Mukherjee, S Hawkins, M Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy |
| title | Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy |
| title_full | Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy |
| title_fullStr | Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy |
| title_full_unstemmed | Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy |
| title_short | Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy |
| title_sort | stomach dose volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy |
| work_keys_str_mv | AT holyoaked stomachdosevolumeparametersandclinicalfactorspredictacutetoxicityinpancreaticcancerchemoradiotherapy AT partridgem stomachdosevolumeparametersandclinicalfactorspredictacutetoxicityinpancreaticcancerchemoradiotherapy AT hurtc stomachdosevolumeparametersandclinicalfactorspredictacutetoxicityinpancreaticcancerchemoradiotherapy AT mukherjees stomachdosevolumeparametersandclinicalfactorspredictacutetoxicityinpancreaticcancerchemoradiotherapy AT hawkinsm stomachdosevolumeparametersandclinicalfactorspredictacutetoxicityinpancreaticcancerchemoradiotherapy |